Alliance Wealth Advisors, LLC /UT

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1893261 Centerville, UT

Position in REGN

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$275,604

-$247,473 QoQ

Shares Held

442

-34.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#963

of 1,322 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Alliance Wealth Advisors, LLC /UT holds $2,238,891 across 5 Biotechnology names. REGN ranks #4 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	7,802	$610,662
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,157	$574,716
3	LGND	Ligand Pharmaceuticals Inc	1,772	$560,111
4	REGN	Regeneron Pharmaceuticals, Inc. This page	442	$275,604
5	KRYS	Krystal Biotech, Inc.	586	$217,798

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$275,604	442	-34.7%	Shares	Other	2026-07-23
2026-03-31	$523,077	677	-30.7%	Shares	Sole	2026-05-12
2025-12-31	$754,116	977	-20.0%	Shares	Sole	2026-02-02
2025-09-30	$686,531	1,221	+28.9%	Shares	Sole	2025-11-10
2025-06-30	$497,175	947	+49.6%	Shares	Sole	2025-08-14
2025-03-31	$401,467	633	+81.9%	Shares	Sole	2025-05-13
2024-12-31	$247,890	348	—	Shares	Sole	2025-01-24
No filing history on record for this holder in this stock.